Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Proponents often stress the potential for meaningful therapeutic outcomes, especially in diseases where conventional medications have proven limited. However, crucially important to assess the considerable financial burden associated with CPI stem cel